Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 8121 - 500 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Reset ↻

Notable Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided Enrollment

Read more ››

By: GlobeNewswire - 22 Feb 2024

Related companies: Notable Labs, Inc

Tarsus Announces Positive Topline Results from Carpo, a Phase 2a Proof-of-Concept “Tick-Kill” Trial Evaluating TP-05 (lotilaner) for the Prevention of Lyme Disease

Read more ››

By: GlobeNewswire - 22 Feb 2024

Related companies: Tarsus Pharmaceuticals, Inc.

Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds

Read more ››

By: GlobeNewswire - 22 Feb 2024

Related companies: MOTUS GI Medical Technologies, Ltd.

Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference

Read more ››

By: GlobeNewswire - 22 Feb 2024

Related companies: Soleno Therapeutics, Inc.

Notice of Nexstim Plc’s 2023 Full Year Results

Read more ››

By: GlobeNewswire - 22 Feb 2024

Related companies: Nexstim Plc

Lisata Therapeutics to Host Year-End 2023 Conference Call on Thursday, February 29, 2024 at 4:30 p.m. Eastern Time

Read more ››

By: GlobeNewswire - 22 Feb 2024

Related companies: Lisata Therapeutics, Inc.

Spectral Receives UKCA Authorization for Burn Indication Expected Commercialization 2nd Half 2024

Read more ››

By: GlobeNewswire - 22 Feb 2024

Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair

Read more ››

By: GlobeNewswire - 22 Feb 2024

Related companies: Kane Biotech Inc.

Amfora Launches First Commercial Products

Read more ››

By: GlobeNewswire - 22 Feb 2024

Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®

Read more ››

By: GlobeNewswire - 22 Feb 2024

Related companies: Mainz Biomed N.V.

ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea

Read more ››

By: GlobeNewswire - 22 Feb 2024

Related companies: ProSomnus Inc.

Capricor Therapeutics to Present Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Update on February 29

Read more ››

By: GlobeNewswire - 22 Feb 2024

Related companies: Capricor Therapeutics, Inc.

Umoja Biopharma to Participate in a Fireside Chat at the Evercore ISI 2024 Emerging Biotech Conference

Read more ››

By: GlobeNewswire - 22 Feb 2024

Related companies: Umoja BioPharma, Inc. | Umoja Biopharma

Ashvattha Therapeutics Announces First Patient Enrolled in Expanded Phase 1/2 Study of Imaging Agent 18F-OP-801 in Additional Neurological Indications

Read more ››

By: GlobeNewswire - 22 Feb 2024

Related companies: Ashvattha Therapeutics, LLC

Kineta to Present New Preclinical Data on its Anti-VISTA Antibody KVA12123 in Acute Myeloid Leukemia at the AACR Blood Cancer Discovery Symposium

Read more ››

By: GlobeNewswire - 22 Feb 2024

Related companies: Kineta, Inc.

Cerevance to Participate at the TD Cowen 44th Annual Health Care Conference

Read more ››

By: GlobeNewswire - 22 Feb 2024

Related companies: Cerevance Inc. | Cerevance Inc.

Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy

Read more ››

By: GlobeNewswire - 22 Feb 2024

Related companies: Avenue Therapeutics, Inc.

SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care Conference

Read more ››

By: GlobeNewswire - 22 Feb 2024

Related companies: SOPHiA GENETICS SA

Gracell Biotechnologies Acquisition Completed

Read more ››

By: GlobeNewswire - 22 Feb 2024

Related companies: Gracell Biotechnology Ltd.

Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024

Read more ››

By: GlobeNewswire - 22 Feb 2024

Related companies: Iovance Biotherapeutics, Inc.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

to the top ↑